MONTREAL, QUEBEC -- (MARKET WIRE) -- November 09, 2006 -- Ambrilia Biopharma Inc.(TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today that it will be hosting a conference call on Tuesday, November 14 at 10:00 AM ET, to discuss its third quarter 2006 financial results and provide an update on its lead development programs.
